We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

VWR Acquires United Biochemicals

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Based in Sanborn, New York and founded in 1996, United Biochemicals manufactures and supplies high purity buffers and biochemicals for research, development and manufacturing processes to biotech, pharmaceutical, cell culture media and medical diagnostic industries.

"United Biochemicals is a strong compliment to VWR's growing life sciences portfolio as VWR continues to make strategic investment into our business," said Manuel Brocke-Benz, President and CEO of VWR. "United Biochemicals' manufacturing expertise, combined with VWR's existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry."

"We are excited to join a trusted, global brand like VWR," shared Fayyaz Hussain, President of United Biochemicals. "This acquisition will allow United Biochemicals to leverage VWR's global sales and marketing organization to grow our business."

Financial details of this acquisition remain confidential.